Series B funding round for Amolyt Pharma raising $80M in September 2021
Series B funding round for Amolyt Pharma raising $80M in September 2021
| Investor | Firm Type | Partner |
|---|
Andera PartnersLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private Equity | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Public | — |
| Private | — |
| Angel | Vincent Brichard |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$305.5M
Top Valuation
-
Amolyt Pharma raised $80M in a Series B round.
The round was announced on 09/01/21.
The round was led by Raphael WISNIEWSKI, Sectoral Asset Management.